Since 1996 WHN is the second oldest medical website on the net, second only to the American Medical Association, servicing over 35,000 physicians and scientists worldwide.

Non-Profit Trusted Source of Non-Commercial Health Information

Notifications
Clear all

Personalized mRNA vaccine targets osteosarcoma relapse in first human use

1 Posts
1 Users
0 Reactions
66 Views
(@Dr. Toussaint)
Joined: 1 month ago
Posts: 6
Topic starter  

In a breakthrough poised to reshape cancer treatment, Houston Methodist has developed the first personalized mRNA cancer vaccine designed to prevent recurrence of osteosarcoma, a rare and aggressive type of bone cancer. This first-of-its-kind treatment was made possible through a compassionate use allowance from the U.S. Food and Drug Administration (FDA) and represents a major step in personalized medicine and cancer care.

https://medicalxpress.com/news/2026-05-personalized-mrna-vaccine-osteosarcoma-relapse.html



   
Quote

Leave a reply

Author Name

Author Email

Title *

Maximum allowed file size is 50MB

 
Preview 0 Revisions Saved